Free Trial

Gyre Therapeutics (GYRE) News Today

Gyre Therapeutics logo
$6.63 -0.37 (-5.30%)
As of 03:55 PM Eastern
This is a fair market value price provided by Massive. Learn more.

GYRE Latest News

High Growth Tech Stocks in US for February 2026
Gyre Therapeutics Advances Hydronidone Toward China Approval
High Growth US Tech Stocks To Watch In October 2025
Gyre Therapeutics CEO Departs
Get Gyre Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for GYRE and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

GYRE Media Mentions By Week

GYRE Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

GYRE
News Sentiment

0.25

0.60

Average
Medical
News Sentiment

GYRE News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

GYRE Articles
This Week

11

2

GYRE Articles
Average Week

Get the Latest News and Ratings for GYRE and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Gyre Therapeutics and its competitors.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools


This page (NASDAQ:GYRE) was last updated on 5/15/2026 by MarketBeat.com Staff.
From Our Partners